Analystreport

BiondVax (NASDAQ: BVXV) was upgraded by analysts at ValuEngine from a "sell" rating to a "hold" rating.

BiondVax Pharmaceuticals Ltd. - American Depositary Shares  (BVXV) 
US:NASDAQ Investor Relations: biondvax.com/investors